|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/532 | |||
| G01N 33/533 | |||
| G01N 33/535 | |||
| G01N 33/543 | |||
| G01N 33/574 |
| (11) | Patento numeris | 2430443 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10720095.8 |
| Europos patento paraiškos padavimo data | 2010-05-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-03-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/034814 |
| Data | 2010-05-13 |
| (87) | Numeris | WO 2010/132723 |
| Data | 2010-11-18 |
| (30) | Numeris | Data | Šalis |
| 178458 P | 2009-05-14 | US | |
| 180787 P | 2009-05-22 | US | |
| 187246 P | 2009-06-15 | US | |
| 228522 P | 2009-07-24 | US | |
| 235646 P | 2009-08-20 | US | |
| 241804 P | 2009-09-11 | US | |
| 262856 P | 2009-11-19 | US | |
| 265227 P | 2009-11-30 | US |
| (72) |
KIM, Phillip, US
LIU, Xinjun, US
KIRKLAND, Richard, US
LEE, Tani, US
YBARRONDO, Belen, US
SINGH, Sharat, US
|
| (73) |
Pierian Holdings, Inc.,
405 Duke Drive, Suite 240, Franklin, TN 37067,
US
|
| (54) | BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY |
| BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY |